Suppr超能文献

确定主动脉瓣狭窄高危人群:主动脉瓣钙化与脂蛋白(a)和低密度脂蛋白胆固醇。

Identifying People at High Risk for Severe Aortic Stenosis: Aortic Valve Calcium Versus Lipoprotein(a) and Low-Density Lipoprotein Cholesterol.

机构信息

Johns Hopkins School of Medicine, Baltimore, MD (N.M.).

Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins School of Medicine, Baltimore, MD (K.J., A.C.R., E.B., O.D., R.S.B., W.S.P., M.J.B., S.P.W.).

出版信息

Circ Cardiovasc Imaging. 2024 Jun;17(6):e016372. doi: 10.1161/CIRCIMAGING.123.016372. Epub 2024 Jun 18.

Abstract

BACKGROUND

Aortic valve calcification (AVC), Lp(a) [lipoprotein(a)], and low-density lipoprotein cholesterol (LDL-C) are associated with severe aortic stenosis (AS). We aimed to determine which of these risk factors were most strongly associated with the risk of incident severe AS.

METHODS

A total of 6792 participants from the MESA study (Multi-Ethnic Study of Atherosclerosis) had computed tomography-quantified AVC, Lp(a), and LDL-C values at MESA visit 1 (2000-2002). We calculated the absolute event rate of incident adjudicated severe AS per 1000 person-years and performed multivariable adjusted Cox proportional hazards regression.

RESULTS

The mean age was 62 years old, and 47% were women. Over a median 16.7-year follow-up, the rate of incident severe AS increased exponentially with higher AVC, regardless of Lp(a) or LDL-C values. Participants with AVC=0 had a very low rate of severe AS even with elevated Lp(a) ≥50 mg/dL (<0.1/1000 person-years) or LDL-C ≥130 mg/dL (0.1/1000 person-years). AVC >0 was strongly associated with severe AS when Lp(a) <50 mg/dL hazard ratio (HR) of 33.8 (95% CI, 16.4-70.0) or ≥50 mg/dL HR of 61.5 (95% CI, 7.7-494.2) and when LDL-C <130 mg/dL HR of 31.1 (95% CI, 14.4-67.1) or ≥130 mg/dL HR of 50.2 (95% CI, 13.2-191.9).

CONCLUSIONS

AVC better identifies people at high risk for severe AS compared with Lp(a) or LDL-C, and people with AVC=0 have a very low long-term rate of severe AS regardless of Lp(a) or LDL-C level. These results suggest AVC should be the preferred prognostic risk marker to identify patients at high risk for severe AS, which may help inform participant selection for future trials testing novel strategies to prevent severe AS.

摘要

背景

主动脉瓣钙化(AVC)、脂蛋白(a)[Lp(a)]和低密度脂蛋白胆固醇(LDL-C)与严重主动脉瓣狭窄(AS)相关。我们旨在确定这些危险因素中哪些与严重 AS 发病风险的关联最强。

方法

共有 6792 名来自 MESA 研究(动脉粥样硬化多民族研究)的参与者在 MESA 访视 1 时(2000-2002 年)进行了计算机断层扫描定量 AVC、Lp(a)和 LDL-C 值检测。我们计算了每 1000 人年发生严重 AS 的绝对事件发生率,并进行了多变量调整的 Cox 比例风险回归。

结果

平均年龄为 62 岁,47%为女性。在中位随访 16.7 年后,无论 Lp(a)或 LDL-C 值如何,AVC 越高,严重 AS 的发生率呈指数增长。即使 Lp(a)≥50mg/dL(<0.1/1000 人年)或 LDL-C≥130mg/dL(0.1/1000 人年),AVC=0 的参与者发生严重 AS 的概率也非常低。当 Lp(a)<50mg/dL 时,AVC>0 与严重 AS 强烈相关(风险比 [HR],33.8;95%置信区间 [CI],16.4-70.0)或 Lp(a)≥50mg/dL 时 HR 为 61.5(95%CI,7.7-494.2),而当 LDL-C<130mg/dL 时 HR 为 31.1(95%CI,14.4-67.1)或 LDL-C≥130mg/dL 时 HR 为 50.2(95%CI,13.2-191.9)。

结论

与 Lp(a)或 LDL-C 相比,AVC 能更好地识别严重 AS 高危人群,而 AVC=0 的人群无论 Lp(a)或 LDL-C 水平如何,长期发生严重 AS 的概率都非常低。这些结果表明,AVC 应作为首选的预后风险标志物,以识别严重 AS 高危患者,这可能有助于为未来的试验提供信息,以选择高危患者进行新型策略预防严重 AS。

相似文献

1
Identifying People at High Risk for Severe Aortic Stenosis: Aortic Valve Calcium Versus Lipoprotein(a) and Low-Density Lipoprotein Cholesterol.
Circ Cardiovasc Imaging. 2024 Jun;17(6):e016372. doi: 10.1161/CIRCIMAGING.123.016372. Epub 2024 Jun 18.
4
Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia.
Atherosclerosis. 2019 Feb;281:25-30. doi: 10.1016/j.atherosclerosis.2018.11.040. Epub 2018 Dec 7.
5
Association of aortic valve calcium with dementia and stroke: The Multi-Ethnic Study of Atherosclerosis.
Atherosclerosis. 2024 Oct;397:117596. doi: 10.1016/j.atherosclerosis.2024.117596. Epub 2024 May 27.
8
Aortic valve calcium as a novel risk marker for kidney function deterioration: The MESA study.
Eur J Intern Med. 2025 Jun;136:49-55. doi: 10.1016/j.ejim.2025.03.037. Epub 2025 Apr 21.
9
Aural toilet (ear cleaning) for chronic suppurative otitis media.
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.
10
Lipoprotein(a) is robustly associated with aortic valve calcium.
Heart. 2021 Sep;107(17):1422-1428. doi: 10.1136/heartjnl-2021-319044. Epub 2021 May 7.

引用本文的文献

2
Novel Circulating Biomarkers in Aortic Valve Stenosis.
Int J Mol Sci. 2025 Feb 22;26(5):1902. doi: 10.3390/ijms26051902.
3
Lipoic Acid Nanoparticles Exert Effective Antiatherosclerosis Effects through Anti-Inflammatory and Antioxidant Pathways.
ACS Omega. 2024 Nov 25;9(49):48642-48649. doi: 10.1021/acsomega.4c07745. eCollection 2024 Dec 10.
4
Role of Lipoprotein (A) in aortic valve stenosis: Novel disease mechanisms and emerging pharmacotherapeutic approaches.
Int J Cardiol Heart Vasc. 2024 Oct 30;55:101543. doi: 10.1016/j.ijcha.2024.101543. eCollection 2024 Dec.

本文引用的文献

1
Prevalence of Aortic Valve Calcium and the Long-Term Risk of Incident Severe Aortic Stenosis.
JACC Cardiovasc Imaging. 2024 Jan;17(1):31-42. doi: 10.1016/j.jcmg.2023.02.018. Epub 2023 May 10.
2
Association of Inflammation and Lipoprotein(a) With Aortic Valve Calcification.
JACC Cardiovasc Imaging. 2023 Sep;16(9):1230-1232. doi: 10.1016/j.jcmg.2023.02.013. Epub 2023 Apr 12.
5
Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: The Copenhagen General Population Study.
Atherosclerosis. 2022 May;349:166-174. doi: 10.1016/j.atherosclerosis.2021.11.029. Epub 2021 Dec 3.
9
Relative Costs of Surgical and Transcatheter Aortic Valve Replacement and Medical Therapy.
Circ Cardiovasc Interv. 2020 May;13(5):e008681. doi: 10.1161/CIRCINTERVENTIONS.119.008681. Epub 2020 May 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验